<DOC>
	<DOC>NCT01648491</DOC>
	<brief_summary>Determine safety and effectiveness of the technique using autologous stem cells in the treatment of urinary incontinence in one male subject.</brief_summary>
	<brief_title>Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use</brief_title>
	<detailed_description>Autologous stem cells will be obtained from the subject by needle biopsy, sent to a lab for multiplication and after about 6 weeks time will be injected into the subjects urethra.</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence, Stress</mesh_term>
	<criteria>urinary incontinence failed urinary incontinence (UI) treatments does not meet inclusion criteria, gender and age limit</criteria>
	<gender>Male</gender>
	<minimum_age>78 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>